Skip to Content

Impotence agents

What are Impotence agents?

Impotence agents treat erectile dysfunction and enable men to have sexual intercourse. Generally, they cause vasodilatation and increase blood flow to the penis and cause an erection.

List of Impotence agents:

Filter by:

Drug Name	View by: Brand \| Generic	Reviews	Avg. Ratings
Caverject Impulse (Pro, More...) generic name: alprostadil		6 reviews		9.4
Staxyn (Pro, More...) generic name: vardenafil		22 reviews		9.1
Edex (Pro, More...) generic name: alprostadil		30 reviews		8.8
Cialis (Pro, More...) generic name: tadalafil		418 reviews		8.6
Caverject (Pro, More...) generic name: alprostadil		8 reviews		8.4
Viagra (Pro, More...) generic name: sildenafil		186 reviews		8.3
Levitra (Pro, More...) generic name: vardenafil		118 reviews		7.8
Yohimbe (Pro, More...) generic name: yohimbine		6 reviews		6.0
Stendra (Pro, More...) generic name: avanafil		42 reviews		5.6
Muse (Pro, More...) generic name: alprostadil		28 reviews		5.2
Prostin VR Pediatric (Pro, More...) generic name: alprostadil		0 reviews	Add rating

See Also

Medical conditions associated with impotence agents:

Recently Approved

moxidectin Moxidectin is a macrocyclic lactone anthelmintic medicine indicated for the treatment of river...
Fulphila Fulphila (pegfilgrastim-jmbd) is a leukocyte growth factor biosimilar to Neulasta (pegfilgrastim)...
Olumiant Olumiant (baricitinib) is a Janus kinase (JAK) inhibitor for the treatment of rheumatoid arthritis.
Consensi Consensi (amlodipine and celecoxib) is a calcium channel blocker and nonsteroidal anti-inflammatory...

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include Micromedex® (updated June 1st, 2018), Cerner Multum™ (updated June 5th, 2018), Wolters Kluwer™ (updated June 4th, 2018) and others. To view content sources and attributions, please refer to our editorial policy.